Molybdenum, xanthine oxidase and riboflavin levels in tamoxifen treated postmenopausal women with breast cancer.
Indian J Med Sci
;
1998 Jun; 52(6): 244-7
Artículo
en Inglés
| IMSEAR
| ID: sea-68661
ABSTRACT
40 cases postmenopausal women with breast cancer constituted the study group and 20 sex and age matched formed the control group. The study group of untreated patients showed nonsignificant decrease in molybdenum but significant decrease in blood xanthine oxidase and riboflavin levels. Tamoxifen treated patients showed nonsignificant increase in molybdenum, after 3 months, significant increase after 6 months and significant increase in xanthine oxidase and riboflavin levels. Thus tamoxifen when given in breast cancer helps in amelioration of the diseased condition.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Riboflavina
/
Tamoxifeno
/
Xantina Oxidasa
/
Neoplasias de la Mama
/
Femenino
/
Humanos
/
Posmenopausia
/
Antineoplásicos Hormonales
/
Persona de Mediana Edad
/
Molibdeno
Tipo de estudio:
Ensayo Clínico Controlado
Idioma:
Inglés
Revista:
Indian J Med Sci
Año:
1998
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS